RT @ImamaNaqviMD: Who and when to DAPT? Our review on post-acute #stroke antiplatelet therapy (looking forward to adding #THALES data) ou…
RT @ImamaNaqviMD: Who and when to DAPT? Our review on post-acute #stroke antiplatelet therapy (looking forward to adding #THALES data) ou…
Who and when to DAPT? Our review on post-acute #stroke antiplatelet therapy (looking forward to adding #THALES data) out in @CochraneStroke @columbianeurons @WNGtweets https://t.co/ObaVUL4ERE https://t.co/T2xvkrmKzK
RT @CochraneLibrary: Are multiple antiplatelet drugs better than fewer antiplatelet drugs for preventing early recurrence after stroke? New…
RT @CochraneLibrary: Are multiple antiplatelet drugs better than fewer antiplatelet drugs for preventing early recurrence after stroke? New…
RT @CochraneLibrary: Are multiple antiplatelet drugs better than fewer antiplatelet drugs for preventing early recurrence after stroke? New…
RT @CochraneLibrary: Are multiple antiplatelet drugs better than fewer antiplatelet drugs for preventing early recurrence after stroke? New…
Are multiple antiplatelet drugs better than fewer antiplatelet drugs for preventing early recurrence after stroke? New systematic review from @CochraneStroke looks at the evidence of 15 RCTs with 17,091 participants. https://t.co/E55aIXUxSf #stroke #Stroke
【コクランレビュー】虚血性脳卒中やTIA後の早期再発予防のための複数抗血小板薬対単剤(抗血小板薬の併用は、単剤と比較して脳卒中の再発リスク減少と関連したが、頭蓋内出血および頭蓋外出血のリスクがより高かった。) #ペ読 https://t.co/MPZuXJN7n5
RT @Links_Medicus: Systematic review: Multiple vs. fewer antiplatelet agents for preventing early recurrence after ischemic stroke or trans…
Systematic review: Multiple vs. fewer antiplatelet agents for preventing early recurrence after ischemic stroke or transient ischemic attack – via @CochraneLibrary https://t.co/tjjn5rx8w5 Summary: https://t.co/srE3MGmnTu
RT @shapiro88: DAPT for all strokes ? https://t.co/SSTkkcSUN0
DAPT for all strokes ? https://t.co/SSTkkcSUN0